Zobrazeno 1 - 10
of 340
pro vyhledávání: '"Mitsuhiro Okamoto"'
Autor:
Shotaro Miyamoto, Yuichi Yoshida, Yoshinori Ozeki, Mitsuhiro Okamoto, Koro Gotoh, Takayuki Masaki, Haruto Nishida, Hiroyuki Fujinami, Toshitaka Shin, Tsutomu Daa, Yoshiki Asayama, Hirotaka Shibata
Publikováno v:
BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Primary aldosteronism (PA) is a common cause of secondary hypertension, whereas pheochromocytoma is a rare cause of it. Thus, concomitant PA and pheochromocytoma is a very rare condition. Case presentation A 52-year-old woman was
Externí odkaz:
https://doaj.org/article/ab7d218a1fe24cd1b274acaac758a1d6
Autor:
Yoshinori Ozeki, Mizuki Kinoshita, Shotaro Miyamoto, Yuichi Yoshida, Mitsuhiro Okamoto, Koro Gotoh, Takayuki Masaki, Kengo Kambara, Hirotaka Shibata
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Since April 2021, the plasma aldosterone concentration has been measured by chemiluminescent enzyme immunoassay (CLEIA) in Japan. In the present study, we developed a new CLEIA using a two-step sandwich method to measure the 24-hour urine aldosterone
Externí odkaz:
https://doaj.org/article/5f7d763609bc4316b116c9f044566324
Autor:
Yoshinori Ozeki, Takayuki Masaki, Akari Kamata, Shotaro Miyamoto, Yuichi Yoshida, Mitsuhiro Okamoto, Koro Gotoh, Hirotaka Shibata
Publikováno v:
Medicines, Vol 9, Iss 9, p 47 (2022)
Background and Objectives: This study aimed to investigate the changes in obesity severity, glucose metabolism, and body composition in patients with obesity and type 2 diabetes mellitus treated with glucagon-like peptide 1 receptor agonist (GLP1-RA)
Externí odkaz:
https://doaj.org/article/02e3d4a475de4468bf1e066fd2624fff
Autor:
Takayuki Masaki, Yoshinori Ozeki, Yuichi Yoshida, Mitsuhiro Okamoto, Shotaro Miyamoto, Koro Gotoh, Hirotaka Shibata
Publikováno v:
Metabolites, Vol 12, Iss 2, p 147 (2022)
We evaluated time-course changes and the relationship between eating behavior and glycemic profile during the treatment of 34 obese type 2 diabetic patients with the glucagon-like peptide-1 receptor agonist (GLP1-RA) semaglutide. Changes in dietary h
Externí odkaz:
https://doaj.org/article/86c95d91c5984632a538022eaad06f9b
Autor:
Kentaro Sada, Yuichi Yoshida, Kanako Shibuta, Kenichi Kimoto, Shotaro Miyamoto, Yoshinori Ozeki, Mitsuhiro Okamoto, Koro Gotoh, Takayuki Masaki, Katsuhiko Yokoyama, Toshiaki Kubota, Hirotaka Shibata
Publikováno v:
Journal of Clinical Endocrinology & Metabolism; Dec2023, Vol. 108 Issue 12, pe1624-e1632, 9p
Autor:
Yoshinori Ozeki, Yukie Tanimura, Satoshi Nagai, Takuya Nomura, Mizuki Kinoshita, Kanako Shibuta, Naoki Matsuda, Shotaro Miyamoto, Yuichi Yoshida, Mitsuhiro Okamoto, Koro Gotoh, Takayuki Masaki, Kengo Kambara, Hirotaka Shibata
Publikováno v:
Diagnostics, Vol 11, Iss 3, p 433 (2021)
In the present study, we developed a new chemiluminescent enzyme immunoassay (CLEIA) using a two-step sandwich method to measure aldosterone concentrations. We investigated serum and plasma aldosterone concentrations in 75 blood samples from 27 patie
Externí odkaz:
https://doaj.org/article/f7a49740777f45dea4369a024ee78575
Autor:
Yuichi Yoshida, Koro Gotoh, Takayuki Masaki, Yoshinori Ozeki, Shotaro Miyamoto, Mitsuhiro Okamoto, Hirotaka Shibata
Publikováno v:
Journal of Hypertension. 41:e284-e285
Autor:
Yuichi Yoshida, Rika Fujiki, Mizuki Kinoshita, Kentaro Sada, Shotaro Miyamoto, Yoshinori Ozeki, Yumi Mori, Naoki Matsuda, Takaaki Noguchi, Hiroshi Nakama, Mitsuhiro Okamoto, Koro Gotoh, Takayuki Masaki, Hirotaka Shibata
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 46(1)
We measured dietary salt intake in 26 patients with primary aldosteronism treated with mineralocorticoid receptor antagonists and evaluated whether plasma renin levels were affected by dietary salt intake pre-treatment and post 6 months of mineraloco
Autor:
Ryota, Takase, Takeshi, Nakata, Kohei, Aoki, Mitsuhiro, Okamoto, Akihiro, Fukuda, Naoya, Fukunaga, Koro, Goto, Takayuki, Masaki, Hirotaka, Shibata
Publikováno v:
Cureus.
Chronic kidney disease (CKD) is known to be a risk factor for falls. In addition, numerous factors such as impaired body balance and loss of muscle mass were reported as risk factors for falls. Patients with CKD often have edema in their lower extrem
Autor:
Tetsuya Kakuma, Yuichi Yoshida, Mitsuhiro Okamoto, Hirotaka Shibata, Takashi Tsutsumi, Yoshikuni Kudo
Publikováno v:
Journal of Endocrinology and Metabolism. 10:131-139